PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCoagulation factor x human
Coagulation factor x human
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
507 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101C90.0102531236
Breast neoplasmsD001943EFO_0003869C5062241332
Plasma cell neoplasmsD05421961641225
Non-hodgkin lymphomaD008228C85.941441121
SyndromeD01357731111519
Hemophilia aD006467EFO_0007267D664553316
HemorrhageD006470MP_0001914R581112510
ThrombosisD01392712137
Diabetes mellitusD003920EFO_0000400E08-E131157
Hemostatic disordersD020141311127
Show 27 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C9523417667
LymphomaD008223C85.914428257
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.062112439
Myeloid leukemia acuteD015470C92.09214434
Myelodysplastic syndromesD009190D468231230
NeoplasmsD009369C8010154427
Myeloid leukemiaD007951C926152223
Lymphoid leukemiaD007945C915114118
NeuroblastomaD009447EFO_0000621761315
Colorectal neoplasmsD015179653213
Show 85 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PreleukemiaD011289314117
Prostatic neoplasmsD011471C6118311
Neoplasm metastasisD009362EFO_00097084710
Graft vs host diseaseD006086D89.811528
AnemiaD000740EFO_0004272D64.9188
MelanomaD008545357
Pancreatic neoplasmsD010190EFO_0003860C25546
PlasmacytomaD010954C90.32416
Ovarian neoplasmsD010051EFO_0003893C56245
T-cell lymphomaD016399415
Show 127 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients55
Myelomonocytic leukemia acuteD015479C92.5112
Neoplasms by histologic typeD00937011
Neoplasms by siteD00937111
Digestive system neoplasmsD00406711
Congenital heart defectsD006330Q24.911
OsteosarcomaD01251611
AstrocytomaD001254EFO_000027111
Epidermolysis bullosaD004820Q8111
Epidermolysis bullosa dystrophicaD016108Q81.211
Show 8 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.966
Metabolic syndromeD024821EFO_0000195E88.81044
Chronic renal insufficiencyD051436N1844
Kidney diseasesD007674EFO_0003086N0844
Cardiovascular diseasesD002318EFO_0000319I9844
OsteoporosisD010024EFO_0003882M81.033
Microvascular anginaD01756622
ExerciseD015444EFO_000048322
Coronary artery diseaseD003324I25.122
Metabolic bone diseasesD00185122
Show 107 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 20,051 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,617 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use